<?xml version="1.0" encoding="UTF-8"?>
<ref id="B35-nanomaterials-09-00227" class="ref">
 <label class="label">35.</label>
 <element-citation publication-type="journal" class="element-citation">
  <person-group person-group-type="author" class="person-group">
   <name class="name">
    <surname class="surname">Muñoz</surname>
    <given-names class="given-names">B.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Rámila</surname>
    <given-names class="given-names">A.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Pérez-Pariente</surname>
    <given-names class="given-names">J.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Díaz</surname>
    <given-names class="given-names">I.</given-names>
   </name>
   <name class="name">
    <surname class="surname">Vallet-Regí</surname>
    <given-names class="given-names">M.</given-names>
   </name>
  </person-group>
  <article-title class="article-title">MCM-41 organic modification as drug delivery rate regulator</article-title>
  <source class="source">Chem. Mater.</source>
  <year class="year">2003</year>
  <volume class="volume">15</volume>
  <fpage class="fpage">500</fpage>
  <lpage class="lpage">503</lpage>
  <pub-id pub-id-type="doi" class="pub-id">10.1021/cm021217q</pub-id>
 </element-citation>
</ref>
